Asthma Trial, Recruiting NCT06625216 Sponsor: Società Italiana di Allergologia, Asma e Immunologia Clinica Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT06625216
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have read, understood, and signed the consent and privacy forms for the study
  • You are older than 12 years of age
  • You have been diagnosed with severe asthma, meaning you are already taking strong asthma medications (high-dose inhaled steroids plus at least one other controller medication, OR oral steroid tablets for more than 6 months per year)
  • Despite being on these medications (or if your treatment were reduced), at least one of the following applies to you: your asthma symptoms are poorly controlled based on a standard questionnaire score; you have had 2 or more asthma attacks in the past 12 months; you have been hospitalised or needed breathing support for an asthma attack in the past 12 months; or your lung function test result is below 80% of the expected level (confirm with trial site)

Who may not be able to join:

  • The trial designers have chosen not to apply any exclusion criteria, in order to get a realistic picture of severe asthma as it occurs in everyday life

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Enrico Marco Heffler, MD, PhD, Personalized Medicine, Asthma and Allergy - IRCCS Humanitas Research Hospital, Rozzano, Italy

Phone: 0282241

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Società Italiana di Allergologia, Asma e Immunologia Clinica
Registry
ClinicalTrials.gov
Start date
17 February 2017
Est. completion
17 February 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Analyzing epidemiological and clinical characteristics of severe asthmatics from SANI registry.; Analyzing epidemiological and clinical characteristics of severe asthmatics from SANI registry.; Analyzing epidemiological and clinical characteristics of severe asthmatics from SANI registry.; Analyzing epidemiological and clinical characteristics of severe asthmatics from SANI registry.; Collecting functional data of severe asthmatics from SANI registry.; Collecting functional data of severe asthmatics from SANI registry.; Assessing inflammatory markers in order to characterize asthma endotypes.;...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov